Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Aug;70(2):204–211. doi: 10.1038/bjc.1994.281

Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.

D J DeFriend 1, E Anderson 1, J Bell 1, D P Wilks 1, C M West 1, R E Mansel 1, A Howell 1
PMCID: PMC2033516  PMID: 8054267

Abstract

We have investigated the effects on breast cancer cell growth of 4-hydroxytamoxifen (4OHT), a conventional antioestrogen with agonist activity, and 7 alpha-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra- 1,3,5,(10)- triene-3,17 beta-diol (ICI 182780), a novel, pure antioestrogen, using established human breast cancer cell lines and cancer cells obtained directly from breast cancer patients with malignant pleural effusions who had relapsed on tamoxifen. The effects of the two agents were assessed using the Courtenay-Mills clonogenic assay, which measures the growth of single cancer cells as colonies suspended in soft agar. The standard assay was modified by the use of defined serum- and phenol red-free growth medium. The growth of oestrogen receptor (ER)-positive MCF-7 cells in the assay was oestrogen responsive. Both antioestrogens inhibited the stimulatory effects of 1 nM oestradiol, but ICI 182780 caused significantly greater inhibition than 4OHT at 0.1-1.0 microM concentrations. In the absence of oestradiol, 4OHT but not ICI 182780 caused significant stimulation of colony formation at low (0.01-1.00 nM) concentrations. Neither antioestrogen had any effects on colony formation by the ER-negative Hs578T cell line. Successful colony formation was obtained in primary cultures from six out of eight malignant effusions. Colony formation was significantly stimulated by 0.1 nM oestradiol in four cases and by 10 nM 40HT in two cases. In contrast, ICI 182780 exhibited no intrinsic stimulatory activity and significantly inhibited both oestradiol- and 4OHT-stimulated cell growth. We conclude that the agonist activity of 4OHT and other conventional antioestrogens may cause treatment failure in some patients by stimulating breast cancer cell growth. The new, pure antioestrogen ICI 182780 is a more potent oestrogen antagonist than 4OHT and exhibits no growth-stimulatory activity. This agent may therefore offer therapeutic advantages over conventional antioestrogens in patients with advanced breast cancer and may be effective after conventional agents have failed.

Full text

PDF
204

Images in this article

208Figure 7
on p.208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardon S., Vignon F., Montcourrier P., Rochefort H. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res. 1987 Mar 1;47(5):1441–1448. [PubMed] [Google Scholar]
  2. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496–2500. doi: 10.1073/pnas.83.8.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Calvo F., Carney D. N., Brower M., Minna J. D. Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity. Br J Cancer. 1983 Nov;48(5):683–688. doi: 10.1038/bjc.1983.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Darbre P. D., Curtis S., King R. J. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res. 1984 Jul;44(7):2790–2793. [PubMed] [Google Scholar]
  6. Darbre P., Yates J., Curtis S., King R. J. Effect of estradiol on human breast cancer cells in culture. Cancer Res. 1983 Jan;43(1):349–354. [PubMed] [Google Scholar]
  7. Devleeschouwer N., Legros N., Olea-Serrano N., Paridaens R., Leclercq G. Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth. Cancer Res. 1987 Nov 15;47(22):5883–5887. [PubMed] [Google Scholar]
  8. Dittrich C., Jakesz R., Wrba F., Havelec L., Haas O., Spona J., Holzner H., Kolb R., Moser K. The human tumour cloning assay in the management of breast cancer patients. Br J Cancer. 1985 Aug;52(2):197–203. doi: 10.1038/bjc.1985.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Endresen L., Tveit K. M., Rugstad H. E., Pihl A. Chemosensitivity measurements of human tumour cells by soft agar assays are influenced by the culture conditions. Br J Cancer. 1985 Jun;51(6):843–852. doi: 10.1038/bjc.1985.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goldenberg G. J., Froese E. K. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro. Cancer Res. 1982 Dec;42(12):5147–5151. [PubMed] [Google Scholar]
  11. Gottardis M. M., Jordan V. C. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res. 1988 Sep 15;48(18):5183–5187. [PubMed] [Google Scholar]
  12. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  13. Howell A., Dodwell D. J., Anderson H., Redford J. Response after withdrawal of tamoxifen and progestogens in advanced breast cancer. Ann Oncol. 1992 Sep;3(8):611–617. doi: 10.1093/oxfordjournals.annonc.a058286. [DOI] [PubMed] [Google Scholar]
  14. Hug V., Haynes M., Rashid R., Spitzer G., Blumenschen G., Hortobagyi G. Improved culture conditions for clonogenic growth of primary human breast tumours. Br J Cancer. 1984 Aug;50(2):207–213. doi: 10.1038/bjc.1984.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jones S. E., Dean J. C., Young L. A., Salmon S. E. The human tumor clonogenic assay in human breast cancer. J Clin Oncol. 1985 Jan;3(1):92–97. doi: 10.1200/JCO.1985.3.1.92. [DOI] [PubMed] [Google Scholar]
  16. Katzenellenbogen B. S., Kendra K. L., Norman M. J., Berthois Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 1987 Aug 15;47(16):4355–4360. [PubMed] [Google Scholar]
  17. Kern D. H., Chien F. W., Morton D. L. Selective effects of insulin and hydrocortisone on colony formation and chemosensitivity of human tumors in soft agar. Int J Cancer. 1984 Jun 15;33(6):807–812. doi: 10.1002/ijc.2910330615. [DOI] [PubMed] [Google Scholar]
  18. Kodama F., Greene G. L., Salmon S. E. Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res. 1985 Jun;45(6):2720–2724. [PubMed] [Google Scholar]
  19. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976 Dec;36(12):4595–4601. [PubMed] [Google Scholar]
  20. Manni A., Wright C., Buck H. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat. 1991 Dec;20(1):43–52. doi: 10.1007/BF01833356. [DOI] [PubMed] [Google Scholar]
  21. Manni A., Wright C., Pontari M., Feil P., Joehl R. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay. J Natl Cancer Inst. 1985 Apr;74(4):767–770. [PubMed] [Google Scholar]
  22. Nomura Y., Tashiro H., Hisamatsu K. Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar. J Natl Cancer Inst. 1990 Jul 4;82(13):1146–1149. doi: 10.1093/jnci/82.13.1146. [DOI] [PubMed] [Google Scholar]
  23. Nomura Y., Tashiro H., Hisamatsu K. In vitro clonogenic growth and metastatic potential of human operable breast cancer. Cancer Res. 1989 Oct 1;49(19):5288–5293. [PubMed] [Google Scholar]
  24. Osborne C. K., Von Hoff D. D., Mullins K. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res Treat. 1985;6(3):229–235. doi: 10.1007/BF01806773. [DOI] [PubMed] [Google Scholar]
  25. Ottestad L., Tveit K. M., Hannisdal E., Skrede M., Nesland J. M., Gundersen S., Pihl A. Colony forming ability of human breast carcinomas: lack of prognostic significance. Br J Cancer. 1989 Aug;60(2):216–219. doi: 10.1038/bjc.1989.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ottestad L., Tveit K. M., Høifødt H. K., Nesland J. M., Vaage S., Høie J., Lund E., Pihl A. Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens. Br J Cancer. 1988 Jul;58(1):8–12. doi: 10.1038/bjc.1988.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pathak M. A., Matrisian L. M., Magun B. E., Salmon S. E. Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. Int J Cancer. 1982 Dec 15;30(6):745–750. doi: 10.1002/ijc.2910300611. [DOI] [PubMed] [Google Scholar]
  28. Reddel R. R., Sutherland R. L. Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Eur J Cancer Clin Oncol. 1984 Nov;20(11):1419–1424. doi: 10.1016/0277-5379(84)90062-2. [DOI] [PubMed] [Google Scholar]
  29. Roos W., Huber P., Oeze L., Eppenberger U. Hormone dependency and the action of tamoxifen in human mammary carcinoma cells. Anticancer Res. 1982 May-Jun;2(3):157–162. [PubMed] [Google Scholar]
  30. Simon W. E., Albrecht M., Trams G., Dietel M., Hölzel F. In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst. 1984 Aug;73(2):313–321. doi: 10.1093/jnci/73.2.313. [DOI] [PubMed] [Google Scholar]
  31. Simon W. E., Hänsel M., Dietel M., Matthiesen L., Albrecht M., Hölzel F. Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells. In Vitro. 1984 Mar;20(3 Pt 1):157–166. doi: 10.1007/BF02618184. [DOI] [PubMed] [Google Scholar]
  32. Smallwood J. A., Morgan G. R., Cooper A., Kirkham N., Williams C. J., Whitehouse J. M., Taylor I. Correlations between clonogenicity and prognostic factors in human breast cancer. Br J Surg. 1984 Feb;71(2):109–111. doi: 10.1002/bjs.1800710209. [DOI] [PubMed] [Google Scholar]
  33. Staquet M., Brown B. W., Jr, Rozencweig M., Van Muylder E., Dodion P., Sanders C. Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary. Am J Clin Oncol. 1987 Dec;10(6):485–490. doi: 10.1097/00000421-198712000-00005. [DOI] [PubMed] [Google Scholar]
  34. Strobl J. S., Lippman M. E. Prolonged retention of estradiol by human breast cancer cells in tissue culture. Cancer Res. 1979 Sep;39(9):3319–3327. [PubMed] [Google Scholar]
  35. Thompson E. W., Katz D., Shima T. B., Wakeling A. E., Lippman M. E., Dickson R. B. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res. 1989 Dec 15;49(24 Pt 1):6929–6934. [PubMed] [Google Scholar]
  36. Vignon F., Bouton M. M., Rochefort H. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1502–1508. doi: 10.1016/0006-291x(87)90819-9. [DOI] [PubMed] [Google Scholar]
  37. Von Hoff D. D., Clark G. M., Stogdill B. J., Sarosdy M. F., O'Brien M. T., Casper J. T., Mattox D. E., Page C. P., Cruz A. B., Sandbach J. F. Prospective clinical trial of a human tumor cloning system. Cancer Res. 1983 Apr;43(4):1926–1931. [PubMed] [Google Scholar]
  38. Wakeling A. E., Dukes M., Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 1991 Aug 1;51(15):3867–3873. [PubMed] [Google Scholar]
  39. Welshons W. V., Wolf M. F., Murphy C. S., Jordan V. C. Estrogenic activity of phenol red. Mol Cell Endocrinol. 1988 Jun;57(3):169–178. doi: 10.1016/0303-7207(88)90072-x. [DOI] [PubMed] [Google Scholar]
  40. Wilks D. P., West C. M. A serum-free medium for the Courtenay-Mills soft agar assay. Int J Cell Cloning. 1991 Nov;9(6):559–569. doi: 10.1002/stem.5530090606. [DOI] [PubMed] [Google Scholar]
  41. Wosikowski K., Küng W., Hasmann M., Löser R., Eppenberger U. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Int J Cancer. 1993 Jan 21;53(2):290–297. doi: 10.1002/ijc.2910530220. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES